People
Julie Ledgerwood
Vaccine Company chief medical officer in its 2024 filing and principal investigator for its ARPA-H A-FAVE flavivirus vaccine project. Previously worked at the NIH Vaccine Research Center.
Roles
Vaccine Company
CurrentChief Medical Officer (2024 filing); ARPA-H Principal Investigator